SouthState’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
SouthState's NBIX Position: Q3 2026 in Review
SouthState held its Neurocrine Biosciences (NBIX) position steady in Q3 2026 at 11 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #1030.
SouthState first reported a position in NBIX in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.87K in Q1 2025. 630 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- SouthState held 11 shares of Neurocrine Biosciences worth $1.56K as of Q3 2026.
- SouthState left its Neurocrine Biosciences share count unchanged in Q3 2026.
- Neurocrine Biosciences made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1030 holding.
- SouthState first reported a position in Neurocrine Biosciences in Q1 2025 and has held it in 7 quarters since.
- SouthState's Neurocrine Biosciences position peaked at $3.87K in Q1 2025.
- 630 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.